• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE TAG CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE TAG CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number TGMR313110
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Unspecified Vascular Problem (4441)
Date of Event 02/11/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Patient medications: propranolol and a cholesterol medicine.According to the conformable gore® tag® thoracic with active control endoprosthesis instructions for use (ifu), complications associated with the use of the gore® tag® thoracic endoprosthesis that may occur and/or require intervention include, but are not limited to, vascular trauma.
 
Event or Problem Description
On (b)(6) 2021, this patient underwent treatment for aortic dissection by implanting gore® tag® conformable thoracic stent graft with active control system (ctag with active control).The patient tolerated the procedure.On follow up images (computed tomography dated (b)(6) 2021, revealed the dissection had progressed distal to implanted device.On (b)(6) 2021, the physician reintervened and implanted a gore® tag® conformable thoracic stent graft with active control system distal to previously implanted device.The dissection was resolved, and the patient tolerated the procedure.
 
Additional Manufacturer Narrative
H6: code 213 ¿ a review of the manufacturing records for the device verified that the lot met all pre-release specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE TAG CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key11386221
Report Number2017233-2021-01713
Device Sequence Number3781535
Product Code MIH
UDI-Device Identifier00733132646777
UDI-Public00733132646777
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
PO40043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date10/29/2023
Device Model NumberTGMR313110
Device Catalogue NumberTGMR313110
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 02/11/2021
Supplement Date Received by Manufacturer02/11/2021
Initial Report FDA Received Date02/26/2021
Supplement Report FDA Received Date06/17/2021
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age48 YR
Patient Weight100
-
-